Barinthus Biotherapeutics Plc (BRNS)
Barinthus Biotherapeutics Market Cap: 29.61M for Jan. 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 1.829M |
| NuCana Plc | 13.73M |
| Autolus Therapeutics Plc | 383.25M |
| Tiziana Life Sciences Ltd. | 170.69M |
| Aptorum Group Ltd. | 7.358M |
Market Cap Related Metrics
| PEG Ratio | -0.0146 |
| Price to Book Value | 0.3510 |
| Price | 0.7251 |
| Earnings Yield | -260.1% |
| PEGY Ratio | -0.0146 |